Hepatitis C: A New Era

Prim Care. 2017 Dec;44(4):631-642. doi: 10.1016/j.pop.2017.07.006. Epub 2017 Oct 5.

Abstract

More than 2 million Americans are infected with hepatitis C virus (HCV), and only about half are aware that they are infected. Primarily blood-borne, risk factors for the virus include injection or intranasal drug use, unregulated tattoos, incarceration, and blood transfusion before 1992. In addition, 75% of those with the virus were born between 1945 and 1965, thus making the baby-boomer cohort a population of screening interest. Because acute and early chronic HCV are often asymptomatic, screening of at-risk individuals is of utmost importance. Left untreated, HCV can go on to produce significant hepatic and extrahepatic manifestations.

Keywords: Direct-acting antivirals; HCV; Hepatic fibrosis; Hepatitis C.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Antiviral Agents / therapeutic use*
  • Biopsy, Needle
  • Chronic Disease
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / physiopathology*
  • Humans
  • Liver Cirrhosis / etiology
  • Liver Function Tests
  • Liver Neoplasms / etiology
  • Primary Health Care
  • Pyrimidine Nucleosides
  • Risk Factors

Substances

  • Antiviral Agents
  • Pyrimidine Nucleosides
  • clitocine